ClinConnect ClinConnect Logo
Search / Trial NCT07157111

Perioprative Outcomes for Children With URTI Symptoms

Launched by AIJUN XU ·

Trial Information

Current as of November 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This study is an observational look at whether having mild upper respiratory tract infection (URTI) symptoms in the two weeks before elective non-heart surgery affects how children recover. Researchers will review past records from Tongji Hospital in Wuhan, China, comparing children who had URTI symptoms (symptom group) with those who did not (control group). The project plans to include about 2,392 children aged 1 to 12 years who had non-cardiac surgery between 2015 and 2024. This is a retrospective study, meaning researchers are analyzing existing data rather than enrolling new patients. Results are not yet available, and the study is currently not recruiting, with estimated start in September 2025 and finishing by late October 2025.

To be eligible, children should be 1 to 12 years old, have an ASA health score of I–III, and be undergoing elective non-cardiac surgery. Those with severe illnesses (like serious heart problems or immune issues), a single fever due to another cause, or day-surgery procedures are excluded. The main thing the study will look at is whether URTI symptoms are linked to more problems after surgery within 7 days, including bleeding, infection, stomach or bowel issues, respiratory problems, or a return of the original disease. They will also track breathing problems during or right after surgery, and how long kids spend in recovery or in the hospital.

Gender

ALL

Eligibility criteria

About Aijun Xu

Aijun Xu is a clinical trial sponsor who provides leadership and oversight for the planning, initiation, and conduct of clinical studies. In this role they ensure regulatory compliance, participant safety, and data integrity by coordinating protocol development, quality assurance, and study governance. They work closely with investigators, contract research organizations, ethics committees, and regulatory authorities to manage timelines, budgets, and reporting obligations. Aijun Xu is committed to advancing rigorous, ethically conducted research that translates into reliable clinical evidence.

Locations

Patients applied

0 patients applied

Trial Officials

aihua Du, Dr.

Study Chair

Tongji Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported